근골격계 공동 연구 및 라이선싱 계약(2016-2026년)

The definitive benchmark for musculoskeletal dealmaking

Musculoskeletal partnering spans a range of degenerative, inflammatory, and injury-related conditions, with deal structures reflecting diverse treatment approaches across pharmaceuticals, biologics, and orthopedic interventions.

This report provides a comprehensive and structured analysis of 509 musculoskeletal collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how musculoskeletal deals are structured in practice, allowing you to:

• Benchmark comparable transactions with confidence
• Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
• Define realistic market parameters
• Clear insight into how deal terms vary by stage, asset type, and partner profile
• Support valuation and structuring decisions with evidence
• Ground internal discussions in real transaction data rather than assumptions
• Understand how leading companies approach dealmaking
• Visibility into partner behaviour and recurring deal structures across a clinically diverse and treatment-focused landscape
• Full visibility into deal structure and execution
• Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

• Rights granted and retained
• Development and commercialization responsibilities
• Financial structures and payment triggers
• Key contractual provisions and protections
• This level of transparency is critical to understanding how value, risk, and control are allocated within musculoskeletal partnerships, particularly across chronic conditions and intervention-driven treatment approaches.
• Designed for real-world BD and strategy use

The report is widely used to:

• Structure and benchmark live transactions
• Prepare for negotiations with well-defined market context
• Evaluate partnership opportunities and counterparties
• Support internal strategy with robust, defensible data
• What's included
• 509 musculoskeletal collaboration and licensing deals
• Financial terms, including upfronts, milestones, and royalties where disclosed
• Fully searchable deal directory (by company, therapy, and technology)
• Direct access to SEC-filed agreements and source documents
• Analysis of deal trends, key transactions, and active dealmakers
• A trusted, evidence-based reference for musculoskeletal dealmaking
• Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how musculoskeletal partnerships are structured, negotiated, and valued.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in musculoskeletal dealmaking

• 2.1. Introduction
• 2.2. Musculoskeletal partnering over the years
• 2.3. Musculoskeletal partnering by deal type
• 2.4. Musculoskeletal partnering by industry sector
• 2.5. Musculoskeletal partnering by stage of development
• 2.6. Musculoskeletal partnering by technology type
• 2.7. Musculoskeletal partnering by therapeutic indication

Chapter 3 - Financial deal terms for musculoskeletal partnering

• 3.1. Introduction
• 3.2. Disclosed financials terms for musculoskeletal partnering
• 3.3. Musculoskeletal partnering headline values
• 3.4. Musculoskeletal deal upfront payments
• 3.5. Musculoskeletal deal milestone payments
• 3.6. Musculoskeletal royalty rates

Chapter 4 - Leading musculoskeletal deals and dealmakers

• 4.1. Introduction
• 4.2. Most active in musculoskeletal partnering
• 4.3. List of most active dealmakers in musculoskeletal
• 4.4. Top musculoskeletal deals by value

Chapter 5 - Musculoskeletal contract document directory

• 5.1. Introduction
• 5.2. Musculoskeletal partnering deals where contract document available

Chapter 6 - Musculoskeletal dealmaking by therapeutic target

• 6.1. Introduction
• 6.2. Deals by musculoskeletal therapeutic target
• Deal directory
• Deal directory - Musculoskeletal deals by company A-Z
• Deal directory - Musculoskeletal deals by technology type
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Musculoskeletal partnering since 2016
• Figure 2: Musculoskeletal partnering by deal type since 2016
• Figure 3: Musculoskeletal partnering by industry sector since 2016
• Figure 4: Musculoskeletal partnering by stage of development since 2016
• Figure 5: Musculoskeletal partnering by technology type since 2016
• Figure 6: Musculoskeletal partnering by indication since 2016
• Figure 7: Musculoskeletal deals with a headline value
• Figure 8: Musculoskeletal deals with upfront payment values
• Figure 9: Musculoskeletal deals with milestone payment
• Figure 10: Musculoskeletal deals with royalty rates
• Figure 11: Active musculoskeletal dealmaking activity since 2016
• Figure 12: Top musculoskeletal deals by value since 2016